Critical Survey: Marwynn (NASDAQ:MWYN) & Capstone Therapeutics (NASDAQ:CAPS)

Capstone Therapeutics (NASDAQ:CAPS) and Marwynn (NASDAQ:MWYN) are both small-cap industrials companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability and dividends.

Risk & Volatility

Capstone Therapeutics has a beta of -1.5, meaning that its share price is 250% less volatile than the S&P 500. Comparatively, Marwynn has a beta of 3.81, meaning that its share price is 281% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Capstone Therapeutics and Marwynn, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Capstone Therapeutics	1	0	0	0	1.00
Marwynn	1	0	0	0	1.00

Insider & Institutional Ownership

2.5% of Capstone Therapeutics shares are held by institutional investors. 39.3% of Capstone Therapeutics shares are held by company insiders. Comparatively, 29.8% of Marwynn shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Capstone Therapeutics and Marwynn’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Capstone Therapeutics	-36.51%	-144.43%	-40.48%
Marwynn	-24.74%	-29.11%	-14.05%

Valuation and Earnings

This table compares Capstone Therapeutics and Marwynn”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Capstone Therapeutics	$48.11 million	0.08	-$21.23 million	($3.35)	-0.06
Marwynn	$4.24 million	4.98	-$3.92 million	($0.07)	-14.93

Marwynn has lower revenue, but higher earnings than Capstone Therapeutics. Marwynn is trading at a lower price-to-earnings ratio than Capstone Therapeutics, indicating that it is currently the more affordable of the two stocks.

Summary

Marwynn beats Capstone Therapeutics on 7 of the 11 factors compared between the two stocks.

About Capstone Therapeutics

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.

About Marwynn

Marwynn Holdings, Inc. is a holding company with no operations other than holding the shares of its two wholly-owned operating subsidiaries, FuAn Enterprise, Inc. (“FuAn”) and Grand Forest Cabinetry Inc (“Grand Forest”), that are in the supply chain business. Through our subsidiaries, we are committed to becoming a leading supply chain company in the U.S. for food, non-alcoholic beverages and indoor home improvement products. Food and Non-Alcoholic Beverages FuAn is a food and non-alcoholic beverage supply chain company that specializes in connecting businesses between different regions, particularly between Asia and the U.S. FuAn’s comprehensive supply chain services include the sourcing of Asian food, snacks, and non-alcoholic beverages, and distributing branded goods to mainstream markets, grocery stores and wholesale/warehouse clubs in the U.S. In addition, FuAn provides supply chain consulting, and market expansion support for businesses. With a focus on sourcing Asian foods and non-alcoholic beverages, FuAn aims at becoming a leading importer and distributor of Asian foods and non-alcoholic beverages to the U.S. markets. — Indoor Home Improvement Grand Forest is an indoor home improvement supply chain provider that focuses on providing kitchen cabinets, flooring, and home improvement products sourced from international suppliers. Grand Forest strives to bring affordable luxury with both aesthetics and practicality to the living space. We focus on sourcing high-quality products from reliable overseas suppliers and distributing them to customers primarily in the San Francisco Bay Area, as we work to expand our capabilities throughout California and across the U.S. We prioritize customer satisfaction and aim to provide exceptional products and services to enhance the homes of our customers. Our principal executive office is located in Irvine, CA.